MDPI and ACS Style
Bianchimani, C.; Dolce, D.; Centrone, C.; Campana, S.; Ravenni, N.; Orioli, T.; Camera, E.; Mergni, G.; Fevola, C.; Bonomi, P.;
et al. Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A Monocentric Prospective Pilot Experience. Int. J. Neonatal Screen. 2022, 8, 46.
https://doi.org/10.3390/ijns8030046
AMA Style
Bianchimani C, Dolce D, Centrone C, Campana S, Ravenni N, Orioli T, Camera E, Mergni G, Fevola C, Bonomi P,
et al. Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A Monocentric Prospective Pilot Experience. International Journal of Neonatal Screening. 2022; 8(3):46.
https://doi.org/10.3390/ijns8030046
Chicago/Turabian Style
Bianchimani, Chiara, Daniela Dolce, Claudia Centrone, Silvia Campana, Novella Ravenni, Tommaso Orioli, Erica Camera, Gianfranco Mergni, Cristina Fevola, Paolo Bonomi,
and et al. 2022. "Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A Monocentric Prospective Pilot Experience" International Journal of Neonatal Screening 8, no. 3: 46.
https://doi.org/10.3390/ijns8030046